Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Role of CAR T-Cell Therapy in Relapsed/Refractory ALL 

Relapsed/Refractory ALL: Inotuzumab Ozogamicin 

Relapsed/Refractory ALL: Evaluating Novel Agents   

Approaching Treatment for Relapsed/Refractory ALL 

MRD-Positive ALL: Personal Approaches to Treatment   

ALL: Therapy for Post-Induction MRD-Positivity 

Acute Lymphoblastic Leukemia: Optimizing MRD Testing 

Acute Lymphoblastic Leukemia: Challenges in MRD Testing 

MRD Testing in ALL: Sensitivity and Availability 

Importance of MRD Testing in Acute Lymphoblastic Leukemia 

Optimizing Allogeneic Transplant Strategies in ALL

Up-front Approaches to Treating Ph-Negative ALL 

Defining Ponatinib's Role in Ph-Positive ALL

Philadelphia Chromosome-Positive ALL: Upfront Approaches 

T-Cell Acute Lymphoblastic Leukemia: Impacting Prognosis 

Acute Lymphoblastic Leukemia: Risk Stratification

Frederick Locke, MD, Moffitt Cancer Center, discusses the results of the ZUMA-6 trial investigating axicabtagene ciloleucel (axi-cel; KTE-C19) in combination with atezolizumab (Tecentriq) for the treatment of patients with refractory diffuse large B-cell lymphoma (DLBCL).

Dr. Locke on the ZUMA-6 Trial of Axi-Cel With Atezolizumab for DLBCL

Advances and Research Needs in Lymphoma

Investigating CAR T-Cell Therapy in Lymphoma

Approval of Acalabrutinib in Mantle Cell Lymphoma

Chronic Lymphocytic Leukemia

 Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy. 

Non-Hodgkin Lymphoma

The OncLive Non-Hodgkin Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on various types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in non-Hodgkin lymphoma.

Mantle Cell Lymphoma

The OncLive Mantle Cell Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on mantle cell lymphoma treatment.  This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, therapeutic advances, and ongoing research in mantle cell lymphoma.

Multiple Myeloma

The OncLive Multiple Myeloma condition center page is a comprehensive resource for clinical news and expert insights on multiple myeloma and how to treat patients with monoclonal antibodies, proteasome inhibitors, bispecific T-cell engagers, immunomodulatory agents, CAR T-cell therapy, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in multiple myeloma.

Myeloproliferative Neoplasms

The OncLive Myeloproliferative Neoplasms condition center is a comprehensive resource for clinical news and expert insights on myeloproliferative neoplasms, including myelofibrosis, polycythemia vera, and essential thrombocythemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in myeloproliferative neoplasms.

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Hematologic Oncology | Specialty